Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 1/2018

01-02-2018 | Letter to the editor

Is a liver biopsy necessary to diagnose hemodialysis-related portal-systemic encephalopathy (HRPSE)? A proposal of the concise diagnostic criteria for HRPSE

Authors: Tsuyoshi Takashima, Sae Hirata, Makoto Fukuda, Motoaki Miyazono, Yuji Ikeda

Published in: Clinical and Experimental Nephrology | Issue 1/2018

Login to get access

Excerpt

To the Editor …
Literature
1.
Sherlock S, Summerskill WH, White LP, Phear EA. Portal-systemic encephalopathy; neurological complications of liver disease. Lancet. 1954;267(6836):454–7.PubMed
2.
3.
Ubara Y, Hoshino J, Tagami T, Sawa N, Katori H, Takemoto F, et al. Hemodialysis-related portal-systemic encephalopathy. Am J Kidney Dis. 2004;44(3):e38–42.CrossRefPubMed
4.
Oi K, Okado T, Togo H, Iimori S, Yui N, Sohara E, et al. Two cases of hemodialysis-associated chronic portal-systemic shunt encephalopathy (CPSE) with opposite changes in the blood ammonia concentrations during hemodialysis: a case report and literature review. Intern Med. 2015;54(11):1375–80. doi:10.​2169/​internalmedicine​.​54.​3488.CrossRefPubMed
5.
Takashima T, Ohtsuka T, Sato S, Yoshizaki M, Kamachi S, Kishi T, et al. Episodic confusion in a haemodilaysis patient due to haemodialysis-related portal-systemic encephalopathy and a shunt between the left portal vein and left external iliac vein. Nephrology. 2017;22(4):332. doi:10.​1111/​nep.​12786.CrossRefPubMed
Metadata
Title
Is a liver biopsy necessary to diagnose hemodialysis-related portal-systemic encephalopathy (HRPSE)? A proposal of the concise diagnostic criteria for HRPSE
Authors
Tsuyoshi Takashima
Sae Hirata
Makoto Fukuda
Motoaki Miyazono
Yuji Ikeda
Publication date
01-02-2018
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-017-1410-0

Other articles of this Issue 1/2018

Clinical and Experimental Nephrology 1/2018 Go to the issue

Original article

Off-pump versus on-pump coronary surgery in patients with chronic kidney disease: a meta-analysis

Original article

The renal pathological findings in Japanese HIV-infected individuals with CKD: a clinical case series from a single center

Original article

Serum adipocyte fatty acid-binding protein level is associated with arterial stiffness quantified with cardio-ankle vascular index in kidney transplant patients

Original article

The incidence of the nephrotic syndrome in childhood in Germany

Original article

Thallium-201 washout rate of stress myocardial perfusion imaging as a predictor of mortality in diabetic kidney disease patients initiating hemodialysis: an observational, follow-up study

Erratum

Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits